Persistent higher high sensitivity C-reactive protein after percutaneous coronary intervention (PCI) predicts higher mortality in patients undergoing PCI with stable coronary artery disease.
26 August 2017 (00:00 - 00:00)
Organised by:
About the speaker

Juntendo University School of Medicine, Tokyo (Japan)
15 More presentations in this session
Doctor C. Mayer (Vienna, AT)
Doctor M. Kechida (Monastir, TN)
Professor Z. Motovska (Prague, CZ)
Professor G. Tse (Hong Kong, CN)
Access the full session
The Event
ESC Congress 2017
26 August - 30 August 2017
